Company plans new, confirmatory Phase 3 clinical trial of LYR-210 for treatment of chronic rhinosinusitis (CRS) without nasal polyps, on path to NDA submission – WATERTOWN, Mass., Nov. 12, 2025 (GLOBE ...
Video Quality Speed 00:00 02:01 President Trump faces criticism from MAGA base over comments on American workers These remarks contrast sharply with an executive order he signed in September, which ...